|Articles|January 18, 2002
FDA NEWS DIGEST -- DECEMBER 31, 2001
Author(s)BioPharm International Editors
Preapproval inspection of anthrax facility, new defribilator, new FDA group on safety and risk, and noodle recall.
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
2
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
3
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
4
Developing Next-Gen Cell Lines Using Targeted Integration
5
